4-乙烯基哌啶-1-甲酸叔丁酯 | 180307-56-6

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 羧酸酯及其衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 4-乙烯基哌啶-1-甲酸叔丁酯
• 中文别名: 1-Boc-4-乙烯基-哌啶；N-BOC-4-乙烯基哌啶
• 英文名称: tert-butyl 4-vinylpiperidine-1-carboxylate
• 英文别名: tert-butyl 4-ethenylpiperidine-1-carboxylate；N-Boc-4-vinylpiperidine；1-Boc-4-vinylpiperidine
• CAS: 180307-56-6
• 化学式: C₁₂H₂₁NO₂
• 分子量: 211.304
• InChiKey: LKUCYFONIRHGSQ-UHFFFAOYSA-N

物化性质

• 沸点：
  268.9±29.0 °C(Predicted)
• 密度：
  1.027±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: tert-Butyl 4-vinylpiperidine-1-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: tert-Butyl 4-vinylpiperidine-1-carboxylate
CAS number: 180307-56-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H21NO2
Molecular weight: 211.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-乙烯基哌啶-1-甲酸叔丁酯 在 咪唑 、 盐酸 、 硼烷四氢呋喃络合物 、 (4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate 、 二氢吡啶 、 碘 、 三苯基膦 、 二苯二硫醚 、 三氟乙酸 、 potassium hydroxide 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 57.0h， 生成 盐酸替罗非班
  参考文献：
  名称：

  一种由烯烃一步合成延长两个碳链的羧酸的方法

  摘要：

  本发明涉及一种由烯烃一步合成延长两个碳链的羧酸的方法，该方法是：在惰性气体保护下，依次将烯烃底物、光催化剂、氢原子转移试剂、α‑卤代乙酸、还原剂、溶剂、质子酸加入反应器中，于常温、25W蓝光照射下反应，得到反应产物；反应产物经稀释、碱化、洗涤、酸化、萃取，得到有机相；最后，有机相经减压蒸馏、柱层析，即得延长两个碳链的羧酸产物；或者反应产物经减压蒸馏、柱层析，即得延长两个碳链的羧酸产物。本发明操作简单，直接合成条件温和，而且避免了传统羧酸化合物合成过程中各类官能团之间的相互转化，提高了这类反应的原子及步骤经济性。同时，本发明方法还可以应用于药物西那卡塞和替罗非班的精简合成中。

  公开号：

  CN111718228B
• 作为产物：
  描述：

  4-(2-溴乙基)哌啶-1-羧酸叔丁酯 在 potassium tert-butylate 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 生成 4-乙烯基哌啶-1-甲酸叔丁酯
  参考文献：
  名称：

  Piperidineacetic acid derivatives useful as fibrinogen antagonist agent

  摘要：

  该发明提供了式（I）的化合物及其药用可接受的衍生物，其中：X代表CH₂-CH₂或CH=CH，Y代表氢原子或苯甲基基团，其中苯基可能被一个或多个卤原子取代。式（I）的化合物抑制血小板聚集。

  公开号：

  US05861414A1

文献信息

• Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
  申请人：Aslanian G. Robert

  公开号：US20070010513A1

  公开（公告）日：2007-01-11

  Disclosed are compounds of the formula or a pharmaceutically acceptable salt thereof, wherein: M 1 and M 3 are CH or N; M 2 is CH, CF or N; Y is —C(═O)—, —C(═S)—, —(CH 2 ) q —, —C(═NOR 7 )— or —SO 1-2 —; Z is a bond or optionally substituted alkylene or alkenylene; R 1 is H, alkyl, alkenyl, or optionally substituted cycloalkyl, aryl, heteroaryl, heterocycloalkyl or a group of the formula: where ring A is a monoheteroaryl ring; R 1 is optionally substituted alkyl, alkenyl, aryl, heteroaryl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; compositions and methods of treating allergy-induced airway responses, congestion, obesity, metabolic syndrome nonalcoholic fatty liver disease, hepatic steatosis, nonalcoholic steatohepatitis, cirrhosis, hepatacellular carcinoma or cognition deficit disorders using said compounds, alone or in combination with other agents.

  揭示了以下化合物的结构式或其药学上可接受的盐，其中： M1和M3为CH或N； M2为CH、CF或N； Y为—C(═O)—、—C(═S)—、—(CH2)q—、—C(═NOR7)—或—SO1-2—；Z为键或可选择地取代的烷基或烯基； R1为H、烷基、烯基，或可选择地取代的环烷基、芳基、杂芳基、杂环烷基或下式的基团： 其中环A为单杂芳基环； R1为可选择地取代的烷基、烯基、芳基、杂芳基、环烷基或杂环烷基；其余变量如规范中所定义；使用这些化合物，单独或与其他药剂结合，治疗过敏引起的气道反应、充血、肥胖、代谢综合征、非酒精性脂肪肝病、肝脂肪变性、非酒精性脂肪性肝炎、肝硬化、肝细胞癌或认知缺陷症状的组合物和治疗方法。
• [EN] BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS BIARYLES D'AMIDE DE PIPÉRIDINE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ATHENEX INC

  公开号：WO2018170225A1

  公开（公告）日：2018-09-20

  The present application is directed to biaryl piperidine amide compounds, or pharmaceutically acceptable salts, solvates, and prodrugs thereof, and methods of use thereof.

  本申请涉及联苯哌啶酰胺化合物，或其药用盐、溶剂合物和前药，以及其使用方法。
• [EN] HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROARYLE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE MER
  申请人：DONG A SOCIO HOLDINGS CO LTD

  公开号：WO2018071343A1

  公开（公告）日：2018-04-19

  Compounds of formula (I) [Formula should be inserted here] and a pharmaceutically acceptable salt thereof, wherein A, R1, R2, R3, R4, R5, R6, R7, R24, X, L, n and p are as defined in the specification, are useful for treating or preventing Mer tyrosine kinase receptor modulated disease or conditions. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.

  式(I)的化合物及其药学上可接受的盐，其中A、R1、R2、R3、R4、R5、R6、R7、R24、X、L、n和p如规范中定义的那样，可用于治疗或预防Mer酪氨酸激酶受体调节的疾病或症状。还描述了式(I)的化合物的药物组合物，以及使用这些化合物和组合物的方法。
• Decarboxylative Negishi Coupling of Redox‐Active Aliphatic Esters by Cobalt Catalysis
  作者：Xu‐Ge Liu、Chu‐Jun Zhou、E. Lin、Xiang‐Lei Han、Shang‐Shi Zhang、Qingjiang Li、Honggen Wang

  DOI：10.1002/anie.201806799

  日期：2018.10

  A cobalt‐catalyzed decarboxylative Negishi coupling reaction of redox‐active aliphatic esters with organozinc reagents was developed. The method enabled efficient alkyl–aryl, alkyl–alkenyl, and alkyl–alkynyl coupling reactions under mild reaction conditions with no external ligand or additive needed. The success of an in situ activation protocol and the facile synthesis of the drug molecule (±)‐preclamol

  开发了氧化还原活性脂族酯与有机锌试剂的钴催化脱羧Negishi偶联反应。该方法可以在温和的反应条件下进行高效的烷基-芳基，烷基-烯基和烷基-炔基偶联反应，而无需外部配体或添加剂。原位激活方案的成功实施和药物分子（±）-preclamol的轻松合成凸显了该方法的合成潜力。机理研究表明，涉及一种根本机制。
• Nickel-Catalyzed Multicomponent Coupling: Synthesis of α-Chiral Ketones by Reductive Hydrocarbonylation of Alkenes
  作者：Jian Chen、Shaolin Zhu

  DOI：10.1021/jacs.1c07851

  日期：2021.9.8

  functionalized α-stereocenter, including enantioenriched chiral α-aryl ketones and α-amino ketones. It uses chiral bisoxazoline as a ligand, silane as a reductant, chloroformate as a safe CO source, and a racemic secondary benzyl chloride or an N-hydroxyphthalimide (NHP) ester of a protected α-amino acid as the alkylation reagent. The benign nature of this process renders this method suitable for late-stage functionalization

  已经开发出一种镍催化、多组分区域选择性和对映选择性偶联，通过顺序加氢甲酰化和羰基化从容易获得的起始材料中进行。这种模块化的多组分加氢官能化策略能够对各种未活化的烯烃进行直接的还原烃基化，以产生各种带有功能化 α-立体中心的不对称二烷基酮，包括对映体富集的手性 α-芳基酮和 α-氨基酮。它使用手性双恶唑啉作为配体，硅烷作为还原剂，氯甲酸酯作为安全的 CO 源，外消旋仲苄基氯或N受保护的 α-氨基酸的 -羟基邻苯二甲酰亚胺 (NHP) 酯作为烷基化试剂。该过程的良性性质使该方法适用于复杂分子的后期功能化。